KMT2A and leukemia: Additionally, downstream of fusion oncoproteins, recruitment of CREBBP and EP300 to chromatin binding sites for the transcription factor MYB is essential for the differentiation block in leukemias initiated by a range of fusions including AML1-ETO and MLL-AF9 (105, 106).